VSTM
Verastem Inc
NASDAQ: VSTM · HEALTHCARE · BIOTECHNOLOGY
$5.46
+1.11% today
Updated 2026-04-30
Market cap
$479.62M
P/E ratio
—
P/S ratio
15.51x
EPS (TTM)
$-3.02
Dividend yield
—
52W range
$4 – $11
Volume
2.0M
Verastem Inc (VSTM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-236.50%
ROE
-1,480.00%
ROA
-61.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2010 | — | $-786000.00 | — | — | — |
| 2011 | — | $-13.68M | — | — | — |
| 2012 | $0.00 | $-31.98M | — | — | — |
| 2013 | $0.00 | $-41.20M | — | — | — |
| 2014 | $0.00 | $-53.37M | — | — | — |
| 2015 | $0.00 | $-57.87M | — | — | — |
| 2016 | $0.00 | $-36.44M | — | — | — |
| 2017 | $0.00 | $-67.80M | — | — | — |
| 2018 | $26.72M | $-72.43M | 97.80% | -354.75% | -271.11% |
| 2019 | $17.46M | $-149.21M | 83.92% | -758.14% | -854.77% |
| 2020 | $88.52M | $-67.73M | 61.88% | -55.76% | -76.51% |
| 2021 | $2.05M | $-71.20M | 100.00% | -2,991.18% | -3,468.10% |
| 2022 | $2.60M | $-73.81M | 100.00% | -2,809.59% | -2,843.30% |
| 2023 | $0.00 | $-87.37M | — | — | — |
| 2024 | $10.00M | $-130.64M | 100.00% | -1,149.56% | -1,306.37% |
| 2025 | $30.91M | $-209.47M | 82.86% | -550.33% | -677.59% |